Levasil BF36 AM

Product Line Levasil colloidal silica

Levasil BF36 AM is an alkaline, aqueous dispersion of colloidal silica that is approximately 25% solids by weight. The silica dispersion is sodium stabilized and the amorphous silica particles carry a negative surface charge. The silica particles are discrete, have a spherical shape, and are present in a narrow particle size distribution. The particles have also been surface modified with aluminum. The physical appearance of the dispersion is a clear liquid, slightly more viscous than water. Levasil BF36 AM is produced for world-wide distribution.

×

Request Sample

Levasil BF36 AM (Levasil colloidal silica)

Personal Details

Usage Details

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The information you share with us are stored and processed according to Nouryon's Privacy Policy.
Cancel Submit
×

Request Quote

Levasil BF36 AM (Levasil colloidal silica)

Personal Details

Expected Purchase Details

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The information you share with us are stored and processed according to Nouryon's Privacy Policy.
Cancel Submit
×

Request info

Levasil BF36 AM (Levasil colloidal silica)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The information you share with us are stored and processed according to Nouryon's Privacy Policy.
  • Brand

    Levasil®
  • Chemical family

    Anionic particles aluminate stabilized
  • CAS number

    7631-86-9
  • Physical form

    Liquid
  • Chemical name

    Colloidal silica
  • Applications

    Levasil BF36 AM is a specialty product designed primarily for the beverage fining market and may be used in applications where biocides must be avoided.

Market Segments

Food and beverage

Functions

  • Flocculant
Read more

Nouryon respects your privacy.

We use essential and non-essential cookies to provide, secure, analyze and improve our services. Learn more in our Cookie Policy.

Click 'Agree' to accept or edit your preferences. You can change settings at any time. 

Edit preferences